1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Chronic Disease Analysis & Statistics 2021 - Europe

Chronic Disease Analysis & Statistics 2021 - Europe

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • Euromonitor International
1-30 of 35 reports

Consumer Values and Behaviour in Poland

  • $ 1325
  • November 2021
  • 57 pages

This report visually explores everyday habits and behaviours that reflect consumers’ beliefs and values, linking behavioural trends with purchase and consumption habits in Poland. Consumer Values ...

  • Poland
  • Leisure
  • Pollution Control
  • Industry analysis

Milk Allergies and the Rise of Non-Cow Dairy

  • $ 1325
  • March 2021
  • 23 pages

Milk allergies continue to be a growing condition among consumers globally. This report analyses key drivers behind the following of dairy-free diets, the opportunities for more easily digestible options, ...

  • United States
  • France
  • Food Allergy
  • Allergy
  • Industry analysis
  • Allergy Prevalence
  • Dairy Products Consumption

Cough, Cold and Allergy (Hay Fever) Remedies in Germany

  • $ 990
  • November 2021
  • 26 pages

With requirements to wear protective face masks in public spaces indoors in addition to some outdoor settings in Germany in 2021, the transmission of viruses in general, including influenza, has consequently ...

  • Germany
  • Allergy
  • Hay
  • Industry analysis
  • Health Insurance Claims
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Lithuania

  • $ 990
  • November 2021
  • 24 pages

Cough, cold and allergy (hay fever) remedies continues to see a sharp deceleration in retail value sales growth during 2021 due to the impact of COVID-19. Indeed, cough, cold and allergy (hay fever) remedies ...

  • Lithuania
  • OTC
  • Hay
  • Industry analysis
  • Health Insurance Claims
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Switzerland

  • $ 990
  • November 2021
  • 26 pages

Cough, cold and allergy (hay fever) remedies registered positive sales growth in 2021 as the impact of the COVID-19 pandemic continued to wane. However, sales growth remained very moderate as most consumers ...

  • Switzerland
  • Hay
  • Allergy
  • Industry analysis
  • Online Retail Sales
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in North Macedonia

  • $ 990
  • October 2021
  • 24 pages

Over the review period, cough, cold and allergy (hay fever) remedies benefited from the self-medication trend in North Macedonia. Nonetheless, as a result of the COVID-19 lockdowns and mandated mask wearing, ...

  • Macedonia
  • Allergy
  • Hay
  • Industry analysis
  • Retail Revenue
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Serbia

  • $ 990
  • October 2021
  • 24 pages

Cough, cold and allergy (hay fever) remedies is expected to record slower declines in retail volume and current value sales over 2021, compared with 2020. The slump in sales in a hitherto strong performing ...

  • Serbia
  • OTC
  • Hay
  • Industry analysis
  • Life Expectancy
  • Labour Force

Cough, Cold and Allergy (Hay Fever) Remedies in Hungary

  • $ 990
  • October 2021
  • 26 pages

Cough, cold and allergy (hay fever) remedies did not register the same explosive growth as analgesics in 2020, with value sales on a par or even lower than pre pandemic times. The same is expected to occu ...

  • Hungary
  • Hay
  • Allergy
  • Industry analysis
  • Online Retail Sales
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Portugal

  • $ 990
  • October 2021
  • 25 pages

Portugal introduced a strict lockdown from January to April 2021 due to a major wave of COVID-19. The lockdown, combined with ongoing social distancing measures and new more stringent hygiene habits such ...

  • Portugal
  • Hay
  • Allergy
  • Industry analysis
  • Online Retail Sales
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Slovenia

  • $ 990
  • October 2021
  • 24 pages

In 2021, decongestants is expected to see a moderate rebound from strong declines in retail volume and current value sales in 2020. Stringent Coronavirus (COVID-19) lockdown measures, such as mask-wearing, ...

  • Slovenia
  • OTC
  • Allergy
  • Industry analysis
  • Birth Rate
  • Disposable Income

Cough, Cold and Allergy (Hay Fever) Remedies in Latvia

  • $ 990
  • October 2021
  • 23 pages

Cough, cold and allergy (hay fever) remedies will see even stronger current value declines in 2021 as COVID-19 measures reduce the potential of catching common colds. Such measures include lockdown restrictions ...

  • Latvia
  • OTC
  • Allergy
  • Industry analysis
  • Life Expectancy
  • Online Expenditure

Cough, Cold and Allergy (Hay Fever) Remedies in Belarus

  • $ 990
  • October 2021
  • 22 pages

COVID-19 continues to stimulate sales of cough and cold remedies in Q1 and Q2 of 2021, as consumers remain cautious and begin treatment as soon as the first symptoms occur. The highest demand is in cough ...

  • Belarus
  • Allergy
  • Hay
  • Industry analysis
  • Over The Counter Drug Sales
  • Online Retail Sales

Cough, Cold and Allergy (Hay Fever) Remedies in Ireland

  • $ 990
  • October 2021
  • 25 pages

Having plunged by almost a quarter during 2020, retail current value sales of cough, cold and allergy (hay fever) remedies will continue to fall in 2021 – albeit at a more modest pace. Measures intended ...

  • Ireland
  • Hay
  • Allergy
  • Industry analysis
  • Life Expectancy
  • Vitamin Sales

Cough, Cold and Allergy (Hay Fever) Remedies in Austria

  • $ 990
  • October 2021
  • 27 pages

Wearing masks, washing hands more regularly, disinfecting surfaces and hands as well as social distancing have reduced the spreading and incidence of colds and the flu significantly. Even though in 2021 ...

  • Austria
  • Allergy
  • Hay
  • Industry analysis
  • Fuel Demand
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Estonia

  • $ 990
  • October 2021
  • 23 pages

Sales of cough, cold and allergy (hay fever) remedies continue to be impacted by COVID-19 in 2021, registering further double-digit current value decline. Consumers continue to take precautions due to ...

  • Estonia
  • OTC
  • Hay
  • Industry analysis
  • Life Expectancy
  • Online Retail Sales

Cough, Cold and Allergy (Hay Fever) Remedies in Bosnia and Herzegovina

  • $ 990
  • October 2021
  • 23 pages

While cough, cold and allergy (hay fever) remedies saw significant growth during the review period on the back of the self-medication trend, it was hit hard by measures introduced to limit the spread of ...

  • Bosnia and Herzegovina
  • Hay
  • Allergy
  • Industry analysis
  • Online Retail Sales
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Romania

  • $ 990
  • October 2021
  • 23 pages

The category suffered a strong decline in 2020 as Romanians were less exposed to germs due to social distancing and spending less time outside. The COVID-19 situation is easing in 2021, with very few restrictions ...

  • Romania
  • Allergy
  • Hay
  • Industry analysis
  • Online Retail Sales
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in the United Kingdom

  • $ 990
  • October 2021
  • 27 pages

Following government measures to stop the spread of COVID-19, the lockdown was extended until mid-Q2 2021. This meant that with fewer opportunities to go out, the general public mostly stayed indoors with ...

  • United Kingdom
  • Hay
  • Allergy
  • Industry analysis
  • Life Expectancy
  • Greenhouse Gas Emissions

Cough, Cold and Allergy (Hay Fever) Remedies in Norway

  • $ 990
  • September 2021
  • 27 pages

Following strong growth in 2020 due to COVID-19 and purchases of cough remedies and nasal sprays for use during self-quarantine, cough, cold and allergy (hay fever) remedies is projected to see a small ...

  • Norway
  • Allergy
  • Hay
  • Industry analysis
  • Online Retail Sales
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Russia

  • $ 990
  • September 2021
  • 26 pages

The epidemiologic situation regarding seasonal cold and flu has improved in Russia in 2021. Due to social distancing, the wearing of face masks and improved hygiene practices, there has not been the usual ...

  • Russia
  • Hay
  • Allergy
  • Industry analysis
  • Disposable Income
  • Birth Rate

Cough, Cold and Allergy (Hay Fever) Remedies in Greece

  • $ 990
  • September 2021
  • 25 pages

Cough, cold and allergy (hay fever) remedies looks set to record a steep decline in total current value sales in 2021, with most product categories also projected to post negative results in volume terms. Cough, ...

  • Greece
  • Allergy
  • Hay
  • Industry analysis
  • Online Retail Sales
  • Prescription Drug Sales

Cough, Cold and Allergy (Hay Fever) Remedies in Croatia

  • $ 990
  • September 2021
  • 22 pages

As was the case for other consumer health products in Croatia, cough, cold and allergy (hay fever) remedies saw heightened sales on the eve of lockdown in 2020 as nervous consumers stocked up on medications ...

  • Croatia
  • Allergy
  • Hay
  • Industry analysis
  • Re-Imbursed Pharmaceutical
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Ukraine

  • $ 990
  • September 2021
  • 26 pages

Cough, cold and allergy (hay fever) remedies are expected to register a value decline in 2021, with social distancing measures imposed to curb the spread of COVID-19, also curbing the spread of the common ...

  • Ukraine
  • OTC
  • Hay
  • Industry analysis
  • Prescription Drug Sales
  • Vitamin Sales

Cough, Cold and Allergy (Hay Fever) Remedies in the Netherlands

  • $ 990
  • September 2021
  • 25 pages

Cough, cold and allergy (hay fever) remedies are expected to see a second year of decline in 2021, with social distancing measures imposed to curb the spread of COVID-19, also curbing the spread of the ...

  • Netherlands
  • Allergy
  • Hay
  • Industry analysis
  • Health Insurance Claims
  • Smoking Prevalence

Cough, Cold and Allergy (Hay Fever) Remedies in Italy

  • $ 990
  • September 2021
  • 26 pages

Sales of cough, cold and allergy (hay fever) remedies are expected to continue to decline significantly in 2021, with a double-digit fall in both current and constant value terms. The demand for cough, ...

  • Italy
  • OTC
  • Allergy
  • Industry analysis
  • Life Expectancy
  • Prescription Drug Sales

Cough, Cold and Allergy (Hay Fever) Remedies in Sweden

  • $ 990
  • September 2021
  • 24 pages

After seeing a notable decline in current value terms in 2020, cough, cold and allergy (hay fever) remedies is set to continue this negative trend in 2021. Cough, Cold and Allergy (Hay Fever) Remedies ...

  • Sweden
  • Allergy
  • Hay
  • Industry analysis
  • Life Expectancy
  • Store Closures

Cough, Cold and Allergy (Hay Fever) Remedies in Slovakia

  • $ 990
  • September 2021
  • 24 pages

The spread of COVID-19 led to consumers using more analgesics or Rx products after talking with their doctors and receiving their recommendations on how to treat the virus. Cold illnesses have been less ...

  • Slovakia
  • Hay
  • Allergy
  • Industry analysis
  • Health Insurance Claims
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Denmark

  • $ 990
  • September 2021
  • 24 pages

Cough, cold and allergy remedies is expected to register a small increase in current value sales in 2021 as the segment corrects itself after the decline in 2020, which was caused by a smaller prevalence ...

  • Denmark
  • OTC
  • Allergy
  • Industry analysis
  • Health Insurance Claims
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Finland

  • $ 990
  • September 2021
  • 23 pages

Cough, cold and allergy (hay fever) remedies is expected to register negative current value growth for the second year running, though the decline will not be as significant as in 2020, when it was in ...

  • Finland
  • OTC
  • Allergy
  • Industry analysis
  • Over The Counter Drug Sales
  • Prescription Drug Sales

Cough, Cold and Allergy (Hay Fever) Remedies in France

  • $ 990
  • September 2021
  • 26 pages

Retail current value sales of cough, cold and allergy (hay fever) remedies will decline for the fifth year in a row during 2021, albeit at a much more modest pace than in the previous year. With measures ...

  • France
  • OTC
  • Allergy
  • Industry analysis
  • Prescription Drug Sales
  • Life Expectancy

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on